Law W R, Mourelatos M G, Krahmer R, Dziki A J, Lynch W H, Ferguson J L
Department of Surgery, University of Illinois, Chicago College of Medicine 60612, USA.
Shock. 1997 Mar;7(3):217-24. doi: 10.1097/00024382-199703000-00011.
Endogenous opioids are known to mediate some of the cardiovascular sequelae of sepsis. Inhibition of adrenergic action has been implicated as a physiological path by which endogenous opioids cause deleterious changes in cardiovascular function during endotoxin shock, but where and to what extent this accounts for changes in regional vascular resistance remains unclear. In this study, we addressed this question by examining the role of alpha-adrenergic actions in cardiovascular performance and the regional perfusion changes caused by naloxone during endotoxin shock. Rats had catheters inserted into the tail artery, left cardiac ventricle, and jugular vein. Twenty-four hours later, rats received saline or endotoxin (2 mg/kg) challenge intravenously over 30 min, followed at 40 min by intravenous naloxone (or saline) treatment (4 mg/kg + 2 mg/kg x h) in the presence or absence of phentolamine (100 micrograms/kg + 600 micrograms/kg x h) or yohimbine (40 micrograms/kg + 4 micrograms/kg x h). Radiolabeled microspheres were used to determine cardiac outputs and blood flows at 0, 30, 60, and 120 min after beginning endotoxin infusion. Naloxone attenuated the endotoxin-induced decline in mean arterial pressure (MAP) and cardiac output (CO), but had no effect on increased systemic vascular resistance (SVR). Phentolamine blocked naloxone's ability to increase MAP and CO, but permitted an increase in SVR by naloxone. In the presence of yohimbine, naloxone still increased MAP, but not CO nor SVR. Regional vascular responses varied, with naloxone demonstrating a vasoconstrictive effect despite alpha-adrenergic receptor blockade in some beds, and no effect in others. The response of individual organs in the hepatosplanchnic circulation was heterogenous as well. These data suggest that some effects of endogenous opioids during endotoxin shock are mediated via inhibition of alpha-adrenergic effects, but that some cardiovascular effects of endogenous opioids are independent of adrenergic control during endotoxin shock.
已知内源性阿片类物质介导脓毒症的一些心血管后遗症。肾上腺素能作用的抑制被认为是内源性阿片类物质在内毒素休克期间导致心血管功能发生有害变化的一条生理途径,但这在何处以及在多大程度上导致区域血管阻力的变化仍不清楚。在本研究中,我们通过研究α-肾上腺素能作用在内毒素休克期间对心血管功能和纳洛酮引起的区域灌注变化中的作用来解决这个问题。将导管插入大鼠的尾动脉、左心室和颈静脉。24小时后,大鼠在30分钟内静脉接受生理盐水或内毒素(2mg/kg)攻击,40分钟后在有或没有酚妥拉明(100μg/kg + 600μg/kg·小时)或育亨宾(40μg/kg + 4μg/kg·小时)存在的情况下静脉给予纳洛酮(或生理盐水)治疗(4mg/kg + 2mg/kg·小时)。在内毒素输注开始后的0、30、60和120分钟使用放射性微球来测定心输出量和血流量。纳洛酮减轻了内毒素诱导的平均动脉压(MAP)和心输出量(CO)下降,但对全身血管阻力(SVR)增加没有影响。酚妥拉明阻断了纳洛酮增加MAP和CO的能力,但允许纳洛酮使SVR增加。在育亨宾存在的情况下,纳洛酮仍增加MAP,但不增加CO和SVR。区域血管反应各不相同,尽管在某些血管床中α-肾上腺素能受体被阻断,纳洛酮仍显示出血管收缩作用,而在其他血管床中则无作用。肝内脏循环中各个器官的反应也是异质性的。这些数据表明,内毒素休克期间内源性阿片类物质的一些作用是通过抑制α-肾上腺素能作用介导的,但内源性阿片类物质的一些心血管作用在内毒素休克期间独立于肾上腺素能控制。